Adverse prognostic factors in AITL
| Adverse prognostic factor . | IPI22 . | PIT23 . | PIAI4 . | AITL score . |
|---|---|---|---|---|
| Age ≥60 y | + | + | + | + |
| ECOG >2 | + | + | + | + |
| LDH > ULN | + | + | ||
| Stage III-IV | + | + | ||
| Extranodal sites ≥2 | + | |||
| Bone marrow involvement | + | |||
| B symptoms | + | |||
| Lymphopenia (<1000/mm3) | + | |||
| Thrombocytopenia (<150 000/mm3) | + | |||
| CRP > ULN | + | |||
| β2M > ULN | + |
| Adverse prognostic factor . | IPI22 . | PIT23 . | PIAI4 . | AITL score . |
|---|---|---|---|---|
| Age ≥60 y | + | + | + | + |
| ECOG >2 | + | + | + | + |
| LDH > ULN | + | + | ||
| Stage III-IV | + | + | ||
| Extranodal sites ≥2 | + | |||
| Bone marrow involvement | + | |||
| B symptoms | + | |||
| Lymphopenia (<1000/mm3) | + | |||
| Thrombocytopenia (<150 000/mm3) | + | |||
| CRP > ULN | + | |||
| β2M > ULN | + |